Alopecia Areata – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2021 To 2032

 Alopecia areata is a common autoimmune disorder that often results in unpredictable hair loss. It is an autoimmune disorder in which a misguided immune system damages hair follicles.

·       Prevalence in the general population is 0.1-0.2%. The lifetime risk of developing alopecia areata is estimated to be 1.7%; Alopecia areata is responsible for 0.7-3% of patients seen by dermatologists.

·       The median age at diagnosis is 33. Male patients may be more likely to be diagnosed in childhood, while females are more likely to present in adolescence. About 60% of people with alopecia areata experience the first hair loss episode before age 20.

Thelansis’s “Alopecia Areata Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2021 To 2032" covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Alopecia Areata treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China).

KOLs insights of Alopecia Areata across 8 MM market from the centre of Excellence/ Public/ Private hospitals participated in the study. Insights around current treatment landscape, epidemiology, clinical characteristics, future treatment paradigm, and Unmet needs.

Alopecia Areata Market Forecast Patient Based Forecast Model (MS. Excel Based Automated Dashboard), which Data Inputs with sourcing, Market Event, and Product Event, Country specific Forecast Model, Market uptake and patient share uptake, Attribute Analysis, Analog Analysis, Disease burden, and pricing scenario, Summary, and Insights.

Thelansis Competitive Intelligence (CI) practice has been established based on a deep understanding of the pharma/biotech business environment to provide an optimized support system to all levels of the decision-making process. It enables business leaders in forward-thinking and proactive decision-making. Thelansis supports scientific and commercial teams in seamless CI support by creating an AI/ ML-based technology-driven platform that manages the data flow from primary and secondary sources.

Read more: Alopecia Areata – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2021 To 2032